Filing Flows › Idexx Laboratories (IDXX) › R&D spending
Idexx Laboratories (IDXX) R&D spending by quarter
Idexx Laboratories' R&D spending was $68.8M in Q3 2026 (third quarter 2026), +5% from Q2 2026. Over the last 7 quarters it ranged from $59.1M (Q1 2025) to $68.8M (Q3 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $68.8M | +5% | +9% |
| Q2 2026 | $65.4M | -0.5% | +6% |
| Q1 2026 | $65.8M | -2% | +11% |
| Q4 2025 | $66.8M | +5% | — |
| Q3 2025 | $63.4M | +2% | — |
| Q2 2025 | $61.9M | +5% | — |
| Q1 2025 | $59.1M | — | — |
Q3 2026 at a glance
Idexx Laboratories, Q3 2026: revenue $1.2B (+10% year over year), operating margin 33.1%, net earnings $317M, operating cash flow $450M. The chart follows the revenue to costs, profit and cash.
Questions
What is Idexx Laboratories' R&D spending?
Idexx Laboratories' R&D spending was $68.8M in Q3 2026 (third quarter 2026), +5% from Q2 2026.
How has Idexx Laboratories' R&D spending changed?
Over the last 7 quarters it ranged from $59.1M (Q1 2025) to $68.8M (Q3 2026).